# ATsens

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atsens

- Industry: Medical Devices & Equipment
- Headquarters: Seongnam, South Korea
- Website: www.atsens.com
- Total disclosed funding: $0.8M
- Latest round: Series C (Mar 9, 2022)
- Investors on record: 1

## About

Founded in 2017, and based in Gyeonggi, South Korea, ATsens operates as a manufacturing company that offers medical devices used for early diagnostic solutions for heart-related diseases. It also develops heart-disease diagnosis software. In March 2022, ATsens raised KRW 1 billion in series C funding from returning investor Sneak Peek Investment. As of 2022, Jongwook Jeong acts as the CEO, of the company with 32 patents in the fields of electrocardiogram, biosignals, and healthcare directly related to business.

The company offers a health care platform that helps to monitor respiratory rate, body temperature, body posture and activity, heart rate, fall detection, pulse oximeter (spo2), continuous blood pressure, and glucose. The company also provides an AT-Patch and an AT-Report used for continuous ECG testing.

## Funding rounds

- Series C, Mar 9, 2022, $0.8M — Sneak Peek Investment

## Investors

- Sneak Peek Investment (https://capitalatlas.ai/funds/sneak-peek-investment) — Series C